Media

Press Kit

Malin Media Pack

> Coming Soon

Reports & Presentations

Interim Financial Statements 2019

> download > go to Reports & Presentations page

Latest Press Releases

RNS Announcements

Investee Companies

Wed, 11 Dec 2019

Holding(s) in Company

Wed, 11 Dec 2019

Holding(s) in Company

Wed, 27 Nov 2019

Sale of 3D4Medical Limited

Thu, 14 Nov 2019

Holding(s) in Company

Wed, 13 Nov 2019

Mycovia early completion of Phase 3 enrolment

News Archive>

11 Feb 2020

Mycovia Pharmaceuticals Initiates Extension Clinical Studies to Further Evaluate Long-Term Efficacy of Oteseconazole (VT-1161) in Patients with Recurrent Vulvovaginal Candidiasis

21 Jan 2020

KNOW Bio – REVIAN® Presents Leading Clinical Trial Results for New Hair Loss Treatment

21 Jan 2020

Mycovia Pharmaceuticals Expands Commercialization Team with Strategic New Hires

08 Jan 2020

KNOW Bio – REVIAN® Inc. Announces Issuance of Landmark Patent Covering the Use of Light to Stimulate the Body to Heal Itself

02 Jan 2020

Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206 for Molluscum Contagiosum

Media Contacts

Malin Media Contact

Tel: +353 (0)1 901 5717

mediarelations@malinplc.com
Ireland - Financial Media Contact

Powerscourt

Tel: +353 (0)1 536 0682

malin@powerscourt-group.com
UK - Financial Media Contact

Consilium Strategic Communications

Tel: +44 (0)20 3709 5700

malin@consilium-comms.com